Join to View Full Profile
601 Elmwood AveRochester, NY 14642
Phone+1 585-273-5573
Dr. Spyropoulos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of New Mexico School of MedicineResidency, Internal Medicine, 1992 - 1995
Perelman School of Medicine at the University of PennsylvaniaClass of 1992
Certifications & Licensure
NY State Medical License 2011 - 2027
NM State Medical License 1993 - 2024
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2016
- Fellow (FACP) American College of Physicians, 2001
Clinical Trials
Publications & Presentations
PubMed
- Advanced Therapy for Intermediate-Risk Pulmonary Embolism.Alex C Spyropoulos, Suresh Vedantham
The New England Journal of Medicine. 2026-05-28 - Fatal Pulmonary Embolism in Professional Athletes: A Window Into a Broader VTE Problem.Behnood Bikdeli, Saskia Middeldorp, Jason H Wasfy, Alex C Spyropoulos, David Jimenez
Journal of the American College of Cardiology. 2026-05-13 - 1 citationsSurgical and procedural bleed risk stratification for anticoagulated patients undergoing planned surgery: guidance from the ISTH SSC Subcommittee on Perioperative and ...Joseph R Shaw, Jameel Abdulrehman, Steffan Frosi Stella, Grigorios I Leontiadis, Jan Steffel
Journal of Thrombosis and Haemostasis. 2026-02-05
Journal Articles
- Treatment of Venous Thromboembolism in Elite Athletes: A Suggested Approach to Individualized AnticoagulationAlex C Spyropoulos, Craig M Kessler, Bhavi Pandya, Seminars in Thrombosis and Hemostasis
Abstracts/Posters
- Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) StudyAlex Spyropoulos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Increased Risk of Death in Acutely Ill Medical Patients with Asymptomatic Proximal Deep Vein Thrombosis or Symptomatic Venous Thromboembolism: Insights from the Magell...Alex C. Spyropoulo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
Feinstein Institutes Research Suggests New Management Protocols for Patients Taking Oral AnticoagulantsSeptember 11th, 2024- When to Stop DOAC Before Urologic SurgeryAugust 26th, 2024
- COVID-19 Patients with Cardiovascular Disease More Likely to Develop Blood Clots Post-Hospital Discharge, Feinstein Institutes StudyMay 23rd, 2023
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
